Evogene Stock Price Prediction
| EVGN Stock | USD 1.65 0.08 4.62% |
Oversold Vs Overbought
27
Oversold | Overbought |
EPS Estimate Next Quarter (0.08) | EPS Estimate Current Year (3.65) | EPS Estimate Next Year (3.46) | Wall Street Target Price 13.5 | EPS Estimate Current Quarter (0.12) |
Using Evogene hype-based prediction, you can estimate the value of Evogene from the perspective of Evogene response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Evogene to buy its stock at a price that has no basis in reality. In that case, they are not buying Evogene because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Evogene after-hype prediction price | USD 1.85 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Evogene |
Evogene After-Hype Price Prediction Density Analysis
As far as predicting the price of Evogene at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Evogene or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Evogene, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Evogene Estimiated After-Hype Price Volatility
In the context of predicting Evogene's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Evogene's historical news coverage. Evogene's after-hype downside and upside margins for the prediction period are 0.09 and 7.23, respectively. We have considered Evogene's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Evogene is dangerous at this time. Analysis and calculation of next after-hype price of Evogene is based on 3 months time horizon.
Evogene Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Evogene is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Evogene backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Evogene, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.21 | 5.26 | 0.07 | 0.48 | 3 Events / Month | 5 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.65 | 1.85 | 12.12 |
|
Evogene Hype Timeline
Evogene is currently traded for 1.65. The entity has historical hype elasticity of 0.07, and average elasticity to hype of competition of -0.48. Evogene is forecasted to increase in value after the next headline, with the price projected to jump to 1.85 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 12.12%, whereas the daily expected return is currently at -1.21%. The volatility of related hype on Evogene is about 1323.27%, with the expected price after the next announcement by competition of 1.17. Evogene currently holds 11.51 M in liabilities with Debt to Equity (D/E) ratio of 0.05, which may suggest the company is not taking enough advantage from borrowing. Evogene has a current ratio of 6.66, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Evogene's use of debt, we should always consider it together with its cash and equity.Given the investment horizon of 90 days the next forecasted press release will be in about 3 days. Check out Evogene Basic Forecasting Models to cross-verify your projections.Evogene Related Hype Analysis
Having access to credible news sources related to Evogene's direct competition is more important than ever and may enhance your ability to predict Evogene's future price movements. Getting to know how Evogene's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Evogene may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| OTLY | Oatly Group AB | 0.10 | 7 per month | 0.00 | (0.11) | 4.69 | (5.80) | 30.62 | |
| PLAY | Dave Busters Entertainment | (2.07) | 11 per month | 2.83 | 0.02 | 5.35 | (4.57) | 14.95 | |
| KO | The Coca Cola | (0.56) | 7 per month | 0.00 | (0.26) | 1.11 | (1.66) | 4.07 | |
| MSN | Emerson Radio | (0.02) | 10 per month | 2.72 | (0.0006) | 6.82 | (5.66) | 16.89 | |
| DEO | Diageo PLC ADR | (0.64) | 9 per month | 0.00 | (0.11) | 2.20 | (2.30) | 8.81 | |
| CNLFF | Canlan Ice Sports | 0.00 | 0 per month | 0.00 | (0.46) | 0.00 | 0.00 | 1.03 | |
| PYTCF | Playtech plc | 0.00 | 0 per month | 0.00 | 0.07 | 0.00 | 0.00 | 21.48 | |
| KDP | Keurig Dr Pepper | 0.01 | 13 per month | 0.00 | (0.20) | 1.46 | (2.08) | 6.67 |
Evogene Additional Predictive Modules
Most predictive techniques to examine Evogene price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Evogene using various technical indicators. When you analyze Evogene charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Evogene Predictive Indicators
The successful prediction of Evogene stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Evogene, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Evogene based on analysis of Evogene hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Evogene's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Evogene's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 460.76 | 174.98 | 43.42 | 41.25 | PTB Ratio | 1.23 | 1.03 | 3.3 | 3.14 |
Story Coverage note for Evogene
The number of cover stories for Evogene depends on current market conditions and Evogene's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Evogene is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Evogene's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Evogene Short Properties
Evogene's future price predictability will typically decrease when Evogene's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Evogene often depends not only on the future outlook of the potential Evogene's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Evogene's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.6 M | |
| Cash And Short Term Investments | 31.1 M |
Check out Evogene Basic Forecasting Models to cross-verify your projections. To learn how to invest in Evogene Stock, please use our How to Invest in Evogene guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evogene. If investors know Evogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evogene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.84) | Revenue Per Share 1.881 | Quarterly Revenue Growth 0.398 | Return On Assets (0.28) | Return On Equity (0.82) |
The market value of Evogene is measured differently than its book value, which is the value of Evogene that is recorded on the company's balance sheet. Investors also form their own opinion of Evogene's value that differs from its market value or its book value, called intrinsic value, which is Evogene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evogene's market value can be influenced by many factors that don't directly affect Evogene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evogene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evogene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evogene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.